# GGPS1 Promoter Variant (rs3806394) Is Associated With Larger Simple Renal Cysts via Reduced GGPPS Expression

**Authors:** Kai Wang, Tianzhen Tang, Tao Xu, Zhen Chen, Liming Gou, Yuqi Wang, Dong Wang, Jing Wu, Xiuxing Wang, Bin Xue, Xianlin Xu

PMC · DOI: 10.1155/humu/8347509 · 2026-03-05

## TL;DR

A genetic variant in the GGPS1 promoter is linked to larger simple renal cysts due to reduced GGPPS expression.

## Contribution

The study identifies a specific promoter variant (rs3806394) associated with decreased GGPPS expression and larger renal cysts.

## Key findings

- GGPPS expression is downregulated in larger simple renal cyst tissues.
- The rs3806394 variant in the GGPS1 promoter reduces promoter activity.
- Low GGPPS levels are independently associated with increased cyst size.

## Abstract

We are aimed at investigating the association between the size of simple renal cyst (SRC) and the expression of geranylgeranyl pyrophosphate synthase (GGPPS), which can induce renal cyst formation after its deletion.

Seventy‐seven patients who received renal cyst decortication were enrolled. Clinical characteristics and tissue sections were collected. We used immunohistochemistry and immunofluorescence to detect the expression and location of GGPPS in SRC tissues. The relationship between GGPPS expression and renal cyst size was evaluated by multivariate linear regression analysis. The tagging SNPs located in GGPS1 promoter were identified and the effect of the rs3806394 locus variant on GGPS1 promoter activity was assessed.

Immunohistochemistry and Western blot analysis revealed that GGPPS expression was downregulated in SRC tissues and that the larger the renal cyst volume was, the lower the expression of GGPPS in the cyst lining epithelial. Multivariate linear regression analysis indicated that low GGPPS levels in SRCs were independently related to large SRC size. Additionally, we reported that the frequency of the rs3806394 variant located in the GGPS1 promoter increased in SRC patients. The variant of the rs3806394 locus could decrease the activity of the GGPS1 promoter.

A reduction in GGPPS expression in the cyst lining epithelium was associated with a risk of larger SRC size. The variant of the rs3806394 locus may be one of the reasons for the differential GGPPS expression in SRC tissues among the patients. These findings offer novel insights into the pathological mechanisms of SRC development.

## Linked entities

- **Genes:** GGPS1 (geranylgeranyl diphosphate synthase 1) [NCBI Gene 9453], GGPS1 (geranylgeranyl diphosphate synthase 1) [NCBI Gene 9453]
- **Proteins:** GGPS1 (geranylgeranyl diphosphate synthase 1)

## Full-text entities

- **Genes:** PKD1 (polycystin 1, transient receptor potential channel interacting) [NCBI Gene 5310] {aka PBP, PC1, Pc-1, TRPP1, eliosin}, MMUT (methylmalonyl-CoA mutase) [NCBI Gene 4594] {aka MCM, MUT}, SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714] {aka ASV, SRC1, THC6, c-SRC, p60-Src}, PKD2 (polycystin 2, transient receptor potential cation channel) [NCBI Gene 5311] {aka APKD2, PC2, PKD4, Pc-2, TRPP2}, HNF1B (HNF1 homeobox B) [NCBI Gene 6928] {aka ADTKD3, FJHN, HNF-1-beta, HNF-1B, HNF1beta, HNF2}, UMOD (uromodulin) [NCBI Gene 7369] {aka ADMCKD2, ADTKD1, FJHN, HNFJ, HNFJ1, MCKD2}, PKHD1 (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) [NCBI Gene 5314] {aka ARPKD, FCYT, FPC, PCYT, PKD4, TIGM1}, GGPS1 (geranylgeranyl diphosphate synthase 1) [NCBI Gene 9453] {aka GGPPS, GGPPS1, MDHLO, MUDHLOV}, FOXA1 (forkhead box A1) [NCBI Gene 3169] {aka HNF3A, TCF3A}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}
- **Diseases:** arteriosclerosis (MESH:D001161), infection (MESH:D007239), lung disease (MESH:D008171), Diabetes mellitus (MESH:D003920), hypertrophy (MESH:D006984), malignant tumors (MESH:D009369), kidney stones (MESH:D007669), CKD (MESH:D051436), inflammatory (MESH:D007249), liver disease (MESH:D008107), albuminuria (MESH:D000419), metabolic syndrome (MESH:D024821), Hypertension (MESH:D006973), renal cystic disease (MESH:D052177), flank pain (MESH:D021501), hematuria (MESH:D006417), congenital anomalies of the kidney and urinary tract (MESH:C566906), primary hyperparathyroidism (MESH:D049950), ischemia (MESH:D007511), renal cystogenesis (MESH:D006030), hyperuricemia (MESH:D033461), autosomal dominant polycystic kidney disease (MESH:D016891), polycystic kidney disease (MESH:D007690), maturity-onset diabetes of the young (MESH:C562772), renal carcinoma (MESH:D002292), SRC (MESH:D003560), Type 2 diabetes (MESH:D003924), kidney damage (MESH:D007674)
- **Chemicals:** Lipofectamine 2000 (MESH:C086724), uric acid (MESH:D014527), vitamin K2 (MESH:D024482), streptomycin (MESH:D013307), polyacrylamide (MESH:C016679), GGPSS (-), geranylgeranyl pyrophosphate (MESH:C002963), penicillin (MESH:D010406), SDS (MESH:D012967), PVDF (MESH:C024865), formaldehyde (MESH:D005557), cholesterol (MESH:D002784), DAPI (MESH:C007293), glycemia (MESH:D001786), calcium (MESH:D002118), CO2 (MESH:D002245), Farnesyl pyrophosphate (MESH:C004808), parathormone (MESH:D010281), ubiquinone (MESH:D014451), isoprenoid (MESH:D013729)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** C > T, rs6688441, rs3806394
- **Cell lines:** MDCK — Canis lupus familiaris (Dog), Spontaneously immortalized cell line (CVCL_0422)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12961355/full.md

---
Source: https://tomesphere.com/paper/PMC12961355